Literature DB >> 3613464

Chronic hyperprolactinemia and plasma lipids in women.

H M Heshmati, G Turpin, J L de Gennes.   

Abstract

Plasma total cholesterol (TC), triglycerides (TG), high-density lipoprotein-cholesterol (HDL-C), and low-density lipoprotein-cholesterol (LDL-C) were studied in 15 hyperprolactinemic women who had a prolactin (PRL) adenoma, in comparison to 15 age-matched control women. In the hyperprolactinemic group, plasma lipids were also correlated to age, excess body weight (EBW), plasma PRL, and estradiol-17 beta (E2). Plasma TC, TG, and LDL-C were similar in both hyperprolactinemic and control women, while plasma HDL-C was significantly lower (P less than 0.01) in the hyperprolactinemic group. The correlation study showed a significant negative correlation between HDL-C and EBW (r = -0.64; P less than 0.02) and a slightly significant positive correlation between TG and PRL (r = 0.54; P less than 0.05). The direct effect of PRL on plasma lipids is difficult to establish since many factors influencing lipid metabolism are altered during hyperprolactinemia.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3613464     DOI: 10.1007/bf01721038

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  21 in total

1.  Effects of prolactin and luteinizing hormone on the cholesterol stores in the mouse testis.

Authors:  A Bartke
Journal:  J Endocrinol       Date:  1971-02       Impact factor: 4.286

2.  Comparative study of human fetal, normal adult, and somatotropic adenoma pituitary function in tissue culture.

Authors:  S Marcovitz; C G Goodyer; H Guyda; R J Gardiner; J Hardy
Journal:  J Clin Endocrinol Metab       Date:  1982-01       Impact factor: 5.958

3.  Circadian phase-dependent prolactin mechanisms in hepatic lipogenesis of a teleost.

Authors:  N D Horseman; A H Meier
Journal:  J Endocrinol       Date:  1979-09       Impact factor: 4.286

4.  Decreased bone density in hyperprolactinemic women.

Authors:  A Klibanski; R M Neer; I Z Beitins; E C Ridgway; N T Zervas; J W McArthur
Journal:  N Engl J Med       Date:  1980-12-25       Impact factor: 91.245

5.  Serum lipids, postheparin plasma lipase activities and glucose tolerance in patients with prolactinoma.

Authors:  R Pelkonen; E A Nikkilä; B Grahne
Journal:  Clin Endocrinol (Oxf)       Date:  1982-04       Impact factor: 3.478

6.  Preliminary report: kinetic studies on the modulation of high-density lipoprotein, apolipoprotein, and subfraction metabolism by sex steroids in a postmenopausal woman.

Authors:  W R Hazzard; S M Haffner; R S Kushwaha; D Applebaum-Bowden; D M Foster
Journal:  Metabolism       Date:  1984-09       Impact factor: 8.694

7.  Serum lipoprotein responses during active and stable weight reduction in reproductive obese females.

Authors:  C I Friedman; J M Falko; S T Patel; M H Kim; H A Newman; H Barrows
Journal:  J Clin Endocrinol Metab       Date:  1982-08       Impact factor: 5.958

8.  Analysis of plasma lipids and apolipoproteins in insulin-dependent and noninsulin-dependent diabetics.

Authors:  E R Briones; S J Mao; P J Palumbo; W M O'Fallon; W Chenoweth; B A Kottke
Journal:  Metabolism       Date:  1984-01       Impact factor: 8.694

9.  Daily rhythms of lipogenesis in fat and lean white-throated sparrows Zonotrichia albicollis.

Authors:  A H Meier
Journal:  Am J Physiol       Date:  1977-02

10.  Correlation of hyperprolactinemia with altered plasma insulin and glucagon: similarity to effects of late human pregnancy.

Authors:  A B Gustafson; M F Banasiak; R K Kalkhoff; T C Hagen; H J Kim
Journal:  J Clin Endocrinol Metab       Date:  1980-08       Impact factor: 5.958

View more
  5 in total

1.  Correlation between serum lipid profile and carotid intima-media thickness in Polycystic Ovarian Syndrome.

Authors:  Sarama Saha; Chandan Sarkar; Subhash Chandra Biswas; R Karim
Journal:  Indian J Clin Biochem       Date:  2008-10-01

2.  Microcirculation and atherothrombotic parameters in prolactinoma patients: a pilot study.

Authors:  Anne Q Reuwer; Brigitte M Sondermeijer; Suzanne Battjes; Rogier van Zijderveld; Danka J F Stuijver; Peter H Bisschop; Marcel Th B Twickler; Joost C M Meijers; Reinier O Schlingemann; Erik S Stroes
Journal:  Pituitary       Date:  2012-12       Impact factor: 4.107

3.  Effects of Pituitary Surgery and High-Dose Cabergoline Therapy on Metabolic Profile in Patients With Prolactinoma Resistant to Conventional Cabergoline Treatment.

Authors:  Rosa Pirchio; Renata S Auriemma; Domenico Solari; Mauro Arnesi; Claudia Pivonello; Mariarosaria Negri; Cristina de Angelis; Luigi M Cavallo; Paolo Cappabianca; Annamaria Colao; Rosario Pivonello
Journal:  Front Endocrinol (Lausanne)       Date:  2021-11-30       Impact factor: 5.555

Review 4.  Metabolic effects of prolactin.

Authors:  Rosa Pirchio; Chiara Graziadio; Annamaria Colao; Rosario Pivonello; Renata S Auriemma
Journal:  Front Endocrinol (Lausanne)       Date:  2022-09-27       Impact factor: 6.055

5.  Metabolic abnormalities in patients with prolactinoma: response to treatment with cabergoline.

Authors:  Nazir A Pala; Bashir A Laway; Raiz A Misgar; Rayees A Dar
Journal:  Diabetol Metab Syndr       Date:  2015-11-14       Impact factor: 3.320

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.